Literature DB >> 19401629

Prevalence of occult hepatitis B virus infection in a general adult population in Korea.

Eun Young Song1, Yeo Min Yun, Myoung Hee Park, Dong Hee Seo.   

Abstract

OBJECTIVES: We investigated the prevalence of hepatitis B virus (HBV) markers and occult HBV infection in a general adult population in Korea.
METHODS: HBsAg, anti-HBs and anti-HBc were analyzed on 1,091 samples of routine medical check-up examinees by chemiluminescence immunoassay. Nucleic acid amplification test (NAT) was performed on 1,047 HBsAg-negative samples by multiplex real-time polymerase chain reaction (PCR) kit for simultaneous detection of HBV, hepatitis C virus, and human immunodeficiency virus (Cobas Taqscreen MPX) in pools of six and reactive pools were resolved to individual samples, and further discriminated by PCR-based assay for HBV (Cobas Ampliscreen HBV).
RESULTS: The prevalences of HBsAg, anti-HBc, and anti-HBs were 4.0, 39.3, and 75.4%, respectively. The prevalence of anti-HBc significantly decreased with decreasing age (p< 0.001). Occult HBV infection was found in 7 (0.7%) of 1,047 HBsAg-negative subjects, and 5 of them were anti-HBc-negative. Sequencing of HBV S gene in 3 cases revealed one wild-type and two mutant strains (W74S, F85Y; T63I, W74S, T131N substitutions).
CONCLUSIONS: This study helps to understand the current status of hepatitis B infection and the prevalence of occult HBV infection in a general adult population in Korea. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401629     DOI: 10.1159/000214633

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  18 in total

1.  Occult hepatitis B infection in the immigrant population of Sicily, Italy.

Authors:  Fabio Tramuto; Carmelo M Maida; Giuseppina M E Colomba; Paola Di Carlo; Giovanni Mazzola; Valentina Li Vecchi; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Immigr Minor Health       Date:  2013-08

2.  Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Authors:  Ban Seok Lee; Eun-Cheol Park; Seung Woo Park; Chung Mo Nam; Jaehoon Roh
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

4.  Mutations associated with occult hepatitis B in HIV-positive South Africans.

Authors:  Eleanor A Powell; Maemu P Gededzha; Michael Rentz; Nare J Rakgole; Selokela G Selabe; Tebogo A Seleise; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Med Virol       Date:  2014-08-27       Impact factor: 2.327

5.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

6.  Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis.

Authors:  Shashi A Gujar; Patricia M Mulrooney-Cousins; Tomasz I Michalak
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

7.  Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients.

Authors:  Jae Young Jang; Soung Won Jeong; Sung Ran Cheon; Sae Hwan Lee; Sang Gyune Kim; Young Koog Cheon; Young Seok Kim; Young Deok Cho; Hong Soo Kim; So Young Jin; Yun Soo Kim; Boo Sung Kim
Journal:  Korean J Hepatol       Date:  2011-09

8.  Pre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity.

Authors:  Hyeongsu Kim; Mina Hur; Hee-Won Moon; Chul Min Park; Jin-Hee Cho; Kyoung Sik Park; Kunsei Lee; Sounghoon Chang
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

9.  Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Authors:  Mohammad Kazemi Arababadi; Gholamhossein Hassanshahi; Ali Akbar Pourfathollah; Ebrahim Rezazadeh Zarandi; Derek Kennedy
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

10.  Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Authors:  Jin-Kyoung Oh; Hai-Rim Shin; Min Kyung Lim; Heeyoun Cho; Dong-Il Kim; Youngmee Jee; Haesun Yun; Keun-Young Yoo
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.